Vial Storage & Shelf-Life

Practical guidance on how long an estradiol-in-oil vial actually keeps, what makes it go bad, and why your refrigerator is not your friend here. This page goes deeper than the storage blurb in Injections: How To — read that one first if you only want the hand-washing-and-don't-microwave version.

The audience here is people self-injecting estradiol valerate (EV), cypionate (EC), or enanthate (EEn) and wondering things like is this two-year-old vial still good? or why did my vial get cloudy when I left it on a cold windowsill?

Two clocks, not one

A vial has two separate shelf-lives running in parallel:

1. Chemical — how long the active drug stays intact in solution
2. Microbiological — how long it stays sterile after you puncture the stopper

For sealed, unopened vials the chemical clock dominates and is measured in years. For opened multi-dose vials the microbiological clock dominates and the default is 28 days from first puncture. These two facts together explain almost every storage rule below.

How long does a sealed vial last?

Years. The clearest public regulatory data point is an oily injectable containing estradiol valerate (combined with norethisterone enanthate) that carries a 60-month approved shelf-life in brown glass ampoules and 48 months in prefilled syringes, both stored at not-above 30 °C and protected from light. Stability programs ran long-term at 30 °C / 65% RH and accelerated at 40 °C / 75% RH for 6 months without negative trend.

The U.S. monoproducts (Delestrogen, Depo-Estradiol, generic EV) don't publish their underlying assay-vs-time datasets, so the publicly visible expiry on a U.S. vial is whatever the manufacturer set, but the chemistry is the same family — there's no reason to think a sealed vial of EV behaves differently in a fundamental way from the WHO-documented EV product.

What this means in practice:

• A sealed, unopened vial stored correctly is almost certainly potent for years past manufacture.
• A vial a few months past its labeled expiry, kept sealed and at room temperature, is overwhelmingly likely to still be on-spec — but you have no lab to confirm and the manufacturer won't stand behind it.
• The labeled expiry date is set by regression confidence bounds, batch variability, and packaging differences, not just by mean drug chemistry. The "true" mean potency typically holds well past expiry; the label is a conservative legal cutoff.

What actually breaks down

Three separate failure modes, each with different triggers:

Failure mode	Trigger	What you'd see	Reversible?
Ester hydrolysis	Trace water + heat over time	Loss of potency; free estradiol appears	No
Oxidation / isomerization	Oxygen, light	Estrone-family degradants form	No
Crystal separation	Cold temperatures	Visible crystals, cloudiness	Yes — redissolves on warming

Hydrolysis is the dominant chemical pathway for esters in oil. Trace water inside the vial slowly cleaves the ester bond, releasing free estradiol plus the corresponding acid (valeric, cypionic, enanthic). The parent ester is what gives you the slow-release pharmacokinetics; once hydrolyzed, the molecule is short-acting estradiol and won't behave as a depot. This process is slow at room temperature — reasoning from the WHO anchor data, the chemical t90 (time to lose 10% of potency) at 25 °C sits in the 6–7 year range under standard kinetic assumptions.

Oxidation generates estrone and related oxidized/aromatized species. This is why every label says protect from light and stable products are sold in amber glass or kept in the carton.

Crystal separation is not chemical degradation. It's a physical phase change — the ester drops out of solution because cold reduces its solubility in the oil. U.S. labels for both Delestrogen and generic EV explicitly note that low-temperature crystals redissolve on warming and the product is unaffected. This is the core reason refrigeration is not recommended even though colder storage would slow chemistry in theory.

Why not refrigerate?

This question comes up constantly. Refrigeration would slow hydrolysis and oxidation, so the chemistry argument seems to favor it. But:

1. Cold causes crystals. EV especially is prone to phase separation at fridge temperatures. The crystals do redissolve on warming, but you have to actually warm the vial each time before drawing, and a partially-warmed vial gives you uneven dose.
2. Cold makes oil viscous. Drawing a 0.2 mL dose of cold castor or sesame oil through a 25 G needle is a workout. Warm oil flows.
3. Condensation risk. Repeatedly moving a vial between fridge and room temperature can drive moisture onto the stopper and into the solution at puncture, accelerating hydrolysis — the opposite of what cold storage was supposed to achieve.
4. The chemistry is already slow at room temperature. If a sealed vial is good for years at 25 °C, the marginal benefit of slowing it further is tiny relative to the practical headaches.

The label rule is the right rule: store at controlled room temperature (20–25 °C, or "not above 30 °C" depending on product), out of direct sunlight and heat. A drawer or medicine cabinet is fine. A summer car is not. A refrigerator is unnecessary and counterproductive.

The 28-day rule and how to think about it

Once the rubber stopper is punctured, you've changed the problem. The vial is no longer hermetically sealed; every needle insertion is a chance for microbes (and trace air and water) to enter. The default guidance for U.S. multi-dose injectables is:

Discard 28 days after first puncture, unless the manufacturer specifies otherwise.

That's the CDC and FDA position, supported by USP <51> antimicrobial effectiveness testing. The preservatives in multi-dose vials (chlorobutanol in Delestrogen 10 mg/mL and Depo-Estradiol; benzyl alcohol plus benzyl benzoate in higher-strength EV) are designed to inhibit growth of microbes introduced during withdrawal — they're not a sterility guarantee.

Community practice vs. label

Many people in MTFG/DIY communities use vials well beyond 28 days, often for the entire vial's worth of doses (which can be many months for a single 5 mL vial dosed weekly). The empirical track record is reassuring — there are not waves of injection-site infections from this practice — but it's a deviation from the validated label and your tolerance for that deviation is your call. The risk-reduction levers are sterile technique, single-use needles, and never injecting if anything looks off.

What dominates real-world in-use risk for an opened vial, in roughly decreasing order:

1. Microbial contamination from poor sterile technique
2. Stopper damage from repeated large-gauge punctures (use a fresh draw needle each time; don't core the stopper)
3. Trace water and air ingress accelerating chemistry
4. Chemical t90 — almost never the binding constraint within a single vial's working life

So if you're worried about whether a 6-month-old opened vial is "still good," the question is really about microbiology and stopper integrity, not whether the estradiol has hydrolyzed. The drug itself is fine. The sterility is what you can't verify.

What to actually do

Situation	What to do
Vial sealed, before stated expiry	Store 20–25 °C, out of light; you're fine
Vial sealed, just past stated expiry	Almost certainly still potent and sterile; legally past-date but chemically intact. Use your own judgment.
Vial sealed, years past expiry	Visual inspection becomes important. Clear, no particles, no color change → likely fine. Cloudy or off-color → discard.
Vial opened, within 28 days	Standard use; rotate sites
Vial opened, 28+ days, no contamination signs	Community practice extends this; not label-supported. Use your judgment and your sterile technique.
Vial cold and crystallized	Warm in your hand or against your body for several minutes. Do not microwave. Do not heat above ~30 °C. Crystals will redissolve.
Vial cloudy after a wet/incompletely-dry needle puncture	Per label, this can happen from trace water on the needle and does not indicate loss of potency. Use judgment; if it persists or worsens, discard.
Vial cloudy at room temperature with no obvious cause	Discard. Could be contamination or unexpected degradation.
Vial color changed (yellow → amber → brown)	Discard. Suggests oxidation or contamination.
Visible particles, floaters, or sediment that doesn't dissolve on warming	Discard.

Storage temperature, in plain numbers

Estradiol ester vials want to live in the same temperature band a human does:

• Ideal: 20–25 °C (room temperature in most homes year-round)
• Acceptable: up to ~30 °C for short periods (transit, summer indoors without AC)
• Avoid: above 30 °C for extended periods (drastically accelerates hydrolysis); below ~15 °C (crystal separation, viscous oil, no benefit)
• Disastrous: above 40 °C or in direct sunlight (a closed car in summer can hit 60+ °C; oxidation and hydrolysis both speed up significantly)

Travel: a vial in checked luggage or in a carry-on is fine for typical flight conditions. Cargo holds get cold but the vial returns to room temperature on landing and any crystals redissolve. The thing to avoid is leaving the vial in a hot car at the destination.

The kinetic argument, for people who want it

Why sealed t90 is multi-year (Arrhenius / pseudo-first-order)

For ester hydrolysis in a sealed oil solution, the relevant kinetic model is pseudo-first-order: water concentration is approximately constant and small, so the rate is proportional to the ester concentration alone. Then the time to lose 10% of potency is:

\[ t_{90} = \frac{\ln(100/90)}{k} = \frac{0.10536}{k} \]

Anchor: WHO-approved EV/NETE prefilled syringe carries a 48-month shelf-life at not-above 30 °C. Treat that as \(t_{90}\) at 30 °C:

\[ k_{30} = \frac{0.10536}{48 \times 30.4375} = 7.21 \times 10^{-5}\ \text{day}^{-1} \]

Apply Arrhenius scaling to drop from 30 °C to 25 °C with a typical pharmaceutical activation energy \(E_a = 75\) kJ/mol:

\[ \frac{k_{25}}{k_{30}} = \exp\!\left[-\frac{75000}{8.314}\!\left(\frac{1}{298.15}-\frac{1}{303.15}\right)\right] \approx 0.607 \]

\[ k_{25} \approx 4.38 \times 10^{-5}\ \text{day}^{-1} \]

\[ t_{90,\,25^\circ\text{C}} = \frac{0.10536}{4.38 \times 10^{-5}} \approx 2406\ \text{days} \approx 79\ \text{months} \]

So if the regulatory-approved 48-month shelf-life at 30 °C is genuinely t90-limited, the same product at room temperature has a chemical t90 around 6.5 years. Sensitivity: varying E_a between 60 and 80 kJ/mol moves t90 at 25 °C between ~72 and ~82 months. The qualitative conclusion — sealed potency is multi-year — is robust.

Anchoring to the 60-month ampoule instead pushes t90 at 25 °C to roughly 8 years.

These are illustrative model numbers, not lab-measured values for any specific U.S. monoproduct, but they're the right order of magnitude and the right conclusion: chemistry is rarely the binding constraint on a vial's working life.

Sources

• WHO Prequalification public assessment reports for estradiol valerate / norethisterone enanthate oily injectable (ampoule and prefilled syringe formats) — primary source for the 60-month and 48-month approved shelf-life figures and the underlying ICH stability study conditions.
• DailyMed labels: Delestrogen (estradiol valerate, sesame oil and castor oil formulations), Depo-Estradiol (estradiol cypionate, cottonseed oil), generic estradiol valerate USP — for storage statements, formulation composition, and the crystal-separation-on-cold and cloudy-from-wet-needle notes.
• Stability-indicating assay for injectable estrogen-androgen combinations in corn oil (1979) — primary chemistry showing ester hydrolysis as the dominant thermal degradation pathway.
• HPLC stability-indicating method for estradiol with seven degradation products, J. Chromatogr. A (2006) — characterizes estrone and Δ9(11)-estrone as primary oxidation/isomerization degradants.
• CDC injection safety guidance — 28-day default in-use period for multi-dose vials.
• FDA in-use stability guidance for multi-dose injectables — same 28-day default with the antimicrobial effectiveness rationale.
• USP <51> Antimicrobial Effectiveness Testing — basis for multi-dose vial preservative validation.
• ICH Q1A(R2) and Q1E — the stability-testing and shelf-life evaluation framework underlying the regulatory shelf-life numbers cited above.